Data / Form D filings / LARASAN PHARMACEUTICAL Corp
LARASAN PHARMACEUTICAL Corp: Form D filing
LARASAN PHARMACEUTICAL Corp, a pharmaceuticals company in Fort Lauderdale, FL, filed a Form D with the SEC in 2014. The latest, on November 20, 2014, reports an offering of $10 million with nothing sold yet.
Find out what LARASAN PHARMACEUTICAL Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 EAST LAS OLAS BLVD., SUITE 1400, Fort Lauderdale, FL, 33301
- Phone
- (754) 300-5060
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1465810
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 20, 2014 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sumair Mitroo | Executive Officer, Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Nov 17, 2014 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LARASAN PHARMACEUTICAL Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.